insights
Perspectives on medicines safety in Africa
Medicines for Africa contributes independent perspectives to strengthen informed action to protect patients from unsafe medicines in African markets. Our thought leadership contributes to the conversation about the nature of regulatory actions needed to strengthen the evolving landscape of medicines and patient safety across the continent.
Our insights aim to support informed dialogue, reinforce shared understanding of medicines safety risks, and contribute constructively to system-level impactful responses that improve patient protection.
Selected contributions
Dialogue Highlights
|
|
Re-imagining patient Safety globallyIn this Utano Podcast episode, Dr. Lenias Hwenda speaks with Prof. Henrietta Hughes, the world’s first Patient Safety Commissioner, about the role of independent patient advocacy in shaping the future of medicines safety and lessons relevant to African health systems.
|
Thought-Leadership
|
Media Engagement
rapid access to Innovation in africaWatch Dr. Lenias Hwenda speak to CNBC Africa Power Lunch about a new long-acting injectable HIV pre-exposure prophylaxis option that may significantly accelerate HIV prevention efforts. The discussion explores implications for rapid regulatory review by African regulators, rapid rollout and patient safety in African markets. This case highlights how effective collaboration between regulators, manufacturers and health systems and other partners can transform safe access to new product innovations in Africa.
|
Our Focus
Our insights focus on:
Our insights focus on:
- Protecting patients from unsafe medicines, including substandard and falsified medical products
- Strengthening regulatory systems and cross-sector collaboration
- Safeguarding the integrity of medicines markets across Africa
Stay connected
For more frequent updates and commentary, follow Medicines for Africa on LinkedIn.
For more frequent updates and commentary, follow Medicines for Africa on LinkedIn.